Robert J. Bauer

2.4k total citations
58 papers, 1.6k citations indexed

About

Robert J. Bauer is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert J. Bauer has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert J. Bauer's work include Monoclonal and Polyclonal Antibodies Research (12 papers), DNA and Nucleic Acid Chemistry (8 papers) and Statistical Methods in Clinical Trials (8 papers). Robert J. Bauer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), DNA and Nucleic Acid Chemistry (8 papers) and Statistical Methods in Clinical Trials (8 papers). Robert J. Bauer collaborates with scholars based in United States, Germany and Japan. Robert J. Bauer's co-authors include Chee M. Ng, Serge Guzy, Russell L. Dedrick, Mark White, Marvin R. Garovoy, Michael J. Murray, Michael A. Trakselis, James L. Kenyon, Amita Joshi and Thomas C. Evans and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Robert J. Bauer

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Bauer United States 23 726 544 294 203 127 58 1.6k
Yanguang Cao United States 23 637 0.9× 355 0.7× 384 1.3× 442 2.2× 70 0.6× 92 1.8k
Binodh DeSilva United States 17 1.0k 1.4× 957 1.8× 669 2.3× 198 1.0× 93 0.7× 60 1.8k
Marian Kelley United States 14 774 1.1× 910 1.7× 555 1.9× 182 0.9× 85 0.7× 23 1.6k
Mark Milton United States 18 516 0.7× 212 0.4× 210 0.7× 381 1.9× 57 0.4× 36 1.2k
Neil Benson United Kingdom 17 1.3k 1.8× 378 0.7× 72 0.2× 258 1.3× 96 0.8× 38 2.1k
Ron J. Keizer Netherlands 20 350 0.5× 310 0.6× 276 0.9× 364 1.8× 124 1.0× 60 2.0k
Russell Weiner United States 21 1.3k 1.8× 1.8k 3.3× 556 1.9× 513 2.5× 203 1.6× 40 3.7k
Federico Goodsaid United States 25 1.1k 1.6× 227 0.4× 67 0.2× 165 0.8× 123 1.0× 60 2.3k
Weirong Wang China 22 1.0k 1.4× 450 0.8× 571 1.9× 181 0.9× 13 0.1× 66 1.7k
Chad Ray United States 14 558 0.8× 453 0.8× 208 0.7× 143 0.7× 84 0.7× 23 1.1k

Countries citing papers authored by Robert J. Bauer

Since Specialization
Citations

This map shows the geographic impact of Robert J. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Bauer more than expected).

Fields of papers citing papers by Robert J. Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Bauer. The network helps show where Robert J. Bauer may publish in the future.

Co-authorship network of co-authors of Robert J. Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Bauer. A scholar is included among the top collaborators of Robert J. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Bauer. Robert J. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koch, Gilbert, et al.. (2024). Computing optimal drug dosing regarding efficacy and safety: the enhanced OptiDose method in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 919–934. 2 indexed citations
2.
Koch, Gilbert, et al.. (2023). Computing optimal drug dosing with OptiDose: implementation in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics. 50(3). 173–188. 4 indexed citations
3.
Yan, Xiaoyu, Robert J. Bauer, Gilbert Koch, et al.. (2021). Delay differential equations based models in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics. 48(6). 763–802. 5 indexed citations
4.
Bauer, Robert J., Thomas C. Evans, & Gregory J. S. Lohman. (2016). The Inhibitory Effect of Non-Substrate and Substrate DNA on the Ligation and Self-Adenylylation Reactions Catalyzed by T4 DNA Ligase. PLoS ONE. 11(3). e0150802–e0150802. 7 indexed citations
5.
Lohman, Gregory J. S., et al.. (2015). A high-throughput assay for the comprehensive profiling of DNA ligase fidelity. Nucleic Acids Research. 44(2). e14–e14. 46 indexed citations
6.
Mohan, Swarna, Debamitra Das, Robert J. Bauer, et al.. (2013). Structure of a Highly Conserved Domain of Rock1 Required for Shroom-Mediated Regulation of Cell Morphology. PLoS ONE. 8(12). e81075–e81075. 17 indexed citations
7.
Bauer, Robert J., et al.. (2013). Novel Interaction of the Bacterial-Like DnaG Primase with the MCM Helicase in Archaea. Journal of Molecular Biology. 425(8). 1259–1273. 9 indexed citations
8.
Bauer, Robert J., et al.. (2013). Assembly and Distributive Action of an Archaeal DNA Polymerase Holoenzyme. Journal of Molecular Biology. 425(23). 4820–4836. 19 indexed citations
9.
Mohan, Swarna, Debamitra Das, Robert J. Bauer, et al.. (2012). Structure of Shroom domain 2 reveals a three-segmented coiled-coil required for dimerization, Rock binding, and apical constriction. Molecular Biology of the Cell. 23(11). 2131–2142. 28 indexed citations
10.
Schneck, Karen, et al.. (2012). Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model. Journal of Pharmacokinetics and Pharmacodynamics. 40(1). 67–80. 23 indexed citations
11.
Gibiansky, Leonid, Ekaterina Gibiansky, & Robert J. Bauer. (2011). Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model. Journal of Pharmacokinetics and Pharmacodynamics. 39(1). 17–35. 29 indexed citations
12.
Goel, Sanjay, Robert J. Bauer, Kavita Desai, et al.. (2007). Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors. Annals of Oncology. 18(10). 1704–1707. 21 indexed citations
13.
Bauer, Robert J., Serge Guzy, & Chee M. Ng. (2007). A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. The AAPS Journal. 9(1). E60–E83. 148 indexed citations
14.
Joshi, Amita, Robert J. Bauer, Peter Kuebler, et al.. (2006). An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis. The Journal of Clinical Pharmacology. 46(1). 10–20. 52 indexed citations
15.
Horwitz, Arnold H., W. S. Ammons, Robert J. Bauer, et al.. (2004). rBPI(10–193) is secreted by CHO cells and retains the activity of rBPI<SUB>21</SUB>. Journal of Endotoxin Research. 10(2). 97–106. 1 indexed citations
16.
Bauer, Robert J., Russell L. Dedrick, Mark White, Michael J. Murray, & Marvin R. Garovoy. (1999). Population Pharmacokinetics and Pharmacodynamics of the Anti-CD11a Antibody hu1124 in Human Subjects with Psoriasis. Journal of Pharmacokinetics and Biopharmaceutics. 27(4). 397–420. 102 indexed citations
17.
Wu, Hsiu‐Mei, Robert E. Williams, R. Little, et al.. (1997). Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein. Journal of Biological Chemistry. 272(4). 2149–2155. 54 indexed citations
18.
Carroll, Stephen F., et al.. (1994). Enhanced Stability in vitro and in vivo of Immunoconjugates Prepared with 5-Methyl-2-iminothiolane. Bioconjugate Chemistry. 5(3). 248–256. 12 indexed citations
19.
Bukowski, Ronald M., G. Thomas Budd, Jacqueline A. Gibbons, et al.. (1994). Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects.. Journal of Clinical Oncology. 12(1). 97–106. 26 indexed citations
20.
Maiorella, B., J L Winkelhake, Duncan Young, et al.. (1993). Effect of Culture Conditions on IgM Antibody Structure, Pharmacokinetics and Activity. Bio/Technology. 11(3). 387–392. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026